Inrig Jula

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Inrig Jula's trades of Travere Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-06 2026-05-06 PlS Planned sale
82,518 +8.3%
273.97
US$3,131,160
82,518 +8.3% 273.97 US$3,131,160
2026-05-06 2026-05-06 PrS Proposed sale
18,198
381.48
US$596,769
18,198 381.48 US$596,769
2026-05-06 2026-05-05 S Sale
108 +23.7%
360.34
US$4,996,608
108 +23.7% 360.34 US$4,996,608
2026-05-05 2026-05-05 PrS Proposed sale
2,174
46.65
US$101,417
2,174 46.65 US$101,417
2026-05-06 2026-05-04 PlS Planned sale
20,000 -15.2%
45.00
US$900,000
20,000 -15.2% 45.00 US$900,000
2026-05-04 2026-05-04 PrS Proposed sale
20,000
45.00
US$900,000
20,000 45.00 US$900,000
2026-04-15 2026-04-15 PlS Planned sale
1,018 -0.9%
42.61
US$43,377
1,018 -0.9% 42.61 US$43,377
2026-04-15 2026-04-15 PrS Proposed sale
1,018
42.61
US$43,377
1,018 42.61 US$43,377
2026-04-15 2026-04-14 S Sale
7,215 -6.0%
41.93
US$302,516
7,215 -6.0% 41.93 US$302,516
2026-04-14 2026-04-14 PrS Proposed sale
7,215
41.93
US$302,516
7,215 41.93 US$302,516
2026-02-05 2026-02-04 PlS Planned sale
232 -0.2%
32.85
US$7,621
232 -0.2% 32.85 US$7,621
2026-02-05 2026-02-04 PlS Planned sale
1,547 -1.4%
32.11
US$49,674
1,547 -1.4% 32.11 US$49,674
2026-02-04 2026-02-04 PrS Proposed sale
1,779
32.21
US$57,299
1,779 32.21 US$57,299
2026-02-03 2026-02-03 S Sale
6,956 -6.1%
32.12
US$223,427
6,956 -6.1% 32.12 US$223,427
2026-02-03 2026-02-03 PrS Proposed sale
6,956
32.12
US$223,429
6,956 32.12 US$223,429
2026-02-03 2026-02-03 S Sale
6,956 -6.1%
32.12
US$223,427
6,956 -6.1% 32.12 US$223,427
2026-01-07 2026-01-06 PlS Planned sale
445 -0.5%
37.75
US$16,799
445 -0.5% 37.75 US$16,799
2026-01-06 2026-01-06 PrS Proposed sale
445
37.75
US$16,799
445 37.75 US$16,799
2026-01-07 2026-01-05 S Sale
2,031 -2.3%
40.18
US$81,606
2,031 -2.3% 40.18 US$81,606
2026-01-05 2026-01-05 PrS Proposed sale
2,031
40.18
US$81,606
2,031 40.18 US$81,606
2025-12-29 2025-12-24 PrS Proposed sale
15,000
42.00
US$630,004
15,000 42.00 US$630,004
2025-12-29 2025-12-24 PlS Planned sale
15,000 -14.5%
42.00
US$630,004
15,000 -14.5% 42.00 US$630,004
2025-07-02 2025-07-01 PlS Planned sale
815 -0.9%
14.65
US$11,940
815 -0.9% 14.65 US$11,940
2025-02-12 2025-02-12 PrS Proposed sale
2,568
23.53
US$60,426
2,568 23.53 US$60,426
2025-02-12 2025-02-12 S Sale
2,568 -2.8%
23.53
US$60,426
2,568 -2.8% 23.53 US$60,426
2025-02-04 2025-02-04 PrS Proposed sale
1,066
20.11
US$21,437
1,066 20.11 US$21,437
2025-02-04 2025-02-04 PlS Planned sale
1,066 -1.3%
20.11
US$21,437
1,066 -1.3% 20.11 US$21,437
2025-02-04 2025-02-03 S Sale
4,207 -4.7%
20.12
US$84,645
4,207 -4.7% 20.12 US$84,645
2025-02-03 2025-02-03 PrS Proposed sale
4,207
20.12
US$84,640
4,207 20.12 US$84,640
2025-01-06 2025-01-06 PlS Planned sale
440 -0.7%
18.76
US$8,254
440 -0.7% 18.76 US$8,254
2025-01-06 2025-01-03 S Sale
2,066 -3.3%
19.10
US$39,461
2,066 -3.3% 19.10 US$39,461
2024-09-10 2024-09-10 PlS Planned sale
684 -1.1%
12.98
US$8,878
684 -1.1% 12.98 US$8,878
2024-09-09 2024-09-09 S Sale
2,191 -3.4%
11.52
US$25,240
2,191 -3.4% 11.52 US$25,240
2024-02-02 2024-02-01 S Sale
2,174 -3.6%
8.53
US$18,547
2,174 -3.6% 8.53 US$18,547
2024-01-05 2024-01-04 PlS Planned sale
440 -1.2%
9.17
US$4,035
440 -1.2% 9.17 US$4,035
2024-01-05 2024-01-03 S Sale
2,069 -5.5%
9.48
US$19,613
2,069 -5.5% 9.48 US$19,613
2023-01-06 2023-01-05 PlS Planned sale
442 -2.5%
20.75
US$9,172
442 -2.5% 20.75 US$9,172
2023-01-06 2023-01-04 S Sale
2,051 -10.3%
20.75
US$42,558
2,051 -10.3% 20.75 US$42,558